Comment on: Khurana et al. The diagnosis of neonatal diabetes in a mother at 25 years of age. Diabetes Care 2012;35:e59

Diabetes Care

Volumn 36, Issue 2, 2013, Pages

  Chakera, Ali J ^a,b   Flanagan, Sarah E ^a   Ellard, Sian ^a,b   Hattersley, Andrew T ^a,b  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA;

ABCC8 GENE; ADULT; AGE DETERMINATION; CASE REPORT; COHORT ANALYSIS; DIABETES CONTROL; DNA CONFORMATION; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; HYPERGLYCEMIA; KCNJ11 GENE; LETTER; NEWBORN DIABETES MELLITUS; PRACTICE GUIDELINE; SEQUENCE ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

DIABETES MELLITUS; FEMALE; HUMANS;

EID: 84873853879     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1750     Document Type: Letter

References (4)

1. Khurana D, Contreras M, Malhotra N, Bargman R. The diagnosis of neonatal diabetes in a mother at 25 years of age. Diabetes Care 2012;35:e59
2. Pearson ER, Flechtner I, Njølstad PR, et al.; Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006; 355:467-477
3. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT; Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonyl-urea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204-209
4. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006;7:352-360